ArticleLasers in medical science2025
Novel application of diode engraving laser for preparing corneal allogenic intrastromal ring segments: a comparative study with femtosecond laser and manual trephine.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corneal allogenic intrastromal ring segments (CAIRS) provide a biocompatible option for the treatment of keratoconus and ectatic disorders, however surgical outcomes rely heavily on pre-operative planning and precise donor tissue preparation. Femtosecond (FS) lasers ensure micron-level accuracy but are costly and often inaccessible, whereas manual trephines are more affordable but limited to fixed geometries and variable thickness. This study evaluated a low-cost automated handheld portable diode engraving laser as a novel alternative for CAIRS preparation. In an ex vivo feasibility study, human donor corneal buttons unsuitable for optical transplantation customized into CAIRS segments using a consumer-grade blue diode engraver (LaserPecker L2, 5 W, 450 nm). Dimensional accuracy, thickness variation with controlled dehydration, stromal interface quality on anterior-segment OCT, and collateral thermal effects were evaluated. As a proof of concept, A diode-engraved laser cut segment was implanted in a keratoconus patient following femtosecond-assisted tunnel creation, and the postoperative visual and tomographic outcomes were documented. Twenty semicircular segments were created without failure. The Mean inner diameter was 6.48 ± 0.05 mm, the outer diameter was 8.01 ± 0.06 mm, and width measured 0.76 ± 0.05 mm (coefficient of variation < 5%). Three engraving passes consistently achieved full stromal penetration (~ 450 μm). Dimensional reproducibility was comparable published FS laser data, while device cost (~ USD 1,200) was over ten-fold lower. Manual trephination proved less precise and lacked customization capability. Preliminary histological analysis confirmed that thermal effects were confined to a narrow coagulation rim with no evidence of deeper stromal alteration. In vivo, a 39-year-old patient improved from UCVA 20/150 to 20/40 and BCVA 20/80 to 20/25, with Kmax reduced from 57.5 D to 44.0 D at one month, and no compications were observed. A consumer-grade diode engraving laser can reliably produce customized CAIRS segments with high precision, minimal collateral damage, and substantially lower cost than FS platforms. This proof-of-concept clinical case demonstrates its potential as an accessible, customizable, and affordable alternative for CAIRS preparation in resource-limited settings.
Indexed as
Identifiers
41091423What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.